Table of Contents

June 1, 2022; Volume 63,Issue 6

A

  1. Ahmed, Hazem

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  2. Allen-Auerbach, Martin

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  3. Allmann, Anne

    1. Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671

  4. Allmann, Jakob

    1. Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671

  5. Ametamey, Simon M.

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  6. Antunes, Inês F.

    1. <sup>18</sup>F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Open Access
      18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Pieter H. Nienhuis, Inês F. Antunes, Andor W.J.M. Glaudemans, Mathilde Jalving, David Leung, Walter Noordzij, Riemer H.J.A. Slart, Erik F.J. de Vries and Geke A.P. Hospers
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 899-905; DOI: https://doi.org/10.2967/jnumed.121.262368

  7. Apostolova, Ivayla

    1. Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck and Ralph Buchert
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 925-930; DOI: https://doi.org/10.2967/jnumed.121.262702

  8. Armstrong, Wesley R.

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  9. Avram, Anca M

    1. SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
      Anca M Avram, Luca Giovanella, Bennett Greenspan, Susan A. Lawson, Markus Luster, Douglas Van Nostrand, Justin G. Peacock, Petra Petranović Ovčariček, Edward Silberstein, Mark Tulchinsky, Frederik A. Verburg and Alexis Vrachimis
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 15N-35N;

B

  1. Bahri, Shadfar

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  2. Bailey, Dale L.

    1. The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
      Sze Ting Lee, Louise M. Emmett, David A. Pattison, Michael S. Hofman, Dale L. Bailey, Melissa J. Latter, Roslyn J. Francis and Andrew M. Scott
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 819-822; DOI: https://doi.org/10.2967/jnumed.122.263996

  3. Bard, Jonathan

    1. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Open Access
      Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, Ignacio Munoz-Sanjuan and Steven Staelens
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 942-947; DOI: https://doi.org/10.2967/jnumed.121.262709

  4. Barker, Christopher A.

    1. <sup>18</sup>F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
      18F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
      Sonia Mahajan, Christopher A. Barker, Audrey Mauguen, Sandra P. D’Angelo, Randy Yeh and Neeta Pandit-Taskar
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 906-911; DOI: https://doi.org/10.2967/jnumed.121.262882

  5. Benson, Taylor

    1. Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
      Phillip H. Kuo, Taylor Benson, Richard Messmann and Michael Groaning
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 816-818; DOI: https://doi.org/10.2967/jnumed.121.263638

  6. Bertoglio, Daniele

    1. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Open Access
      Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, Ignacio Munoz-Sanjuan and Steven Staelens
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 942-947; DOI: https://doi.org/10.2967/jnumed.121.262709

  7. Boellaard, Ronald

    1. Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer <sup>18</sup>F-FDG PET Radiomics
      Open Access
      Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics
      Guilherme D. Kolinger, David Vállez García, Gerbrand Maria Kramer, Virginie Frings, Gerben J.C. Zwezerijnen, Egbert F. Smit, Adrianus Johannes de Langen, Irène Buvat and Ronald Boellaard
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 919-924; DOI: https://doi.org/10.2967/jnumed.121.262660

  8. Brand, Christian

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  9. Buchert, Ralph

    1. Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck and Ralph Buchert
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 925-930; DOI: https://doi.org/10.2967/jnumed.121.262702

  10. Buciuc, Marina

    1. Relationship Between <sup>18</sup>F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Relationship Between 18F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Keith A. Josephs, Nirubol Tosakulwong, Stephen D. Weigand, Marina Buciuc, Val J. Lowe, Dennis W. Dickson and Jennifer L. Whitwell
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 931-935; DOI: https://doi.org/10.2967/jnumed.121.262685

  11. Buvat, Irène

    1. Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer <sup>18</sup>F-FDG PET Radiomics
      Open Access
      Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics
      Guilherme D. Kolinger, David Vállez García, Gerbrand Maria Kramer, Virginie Frings, Gerben J.C. Zwezerijnen, Egbert F. Smit, Adrianus Johannes de Langen, Irène Buvat and Ronald Boellaard
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 919-924; DOI: https://doi.org/10.2967/jnumed.121.262660

C

  1. Cai, Weibo

    1. PET with a 68Ga-Labeled FAPI Dimer: Moving Toward Theranostics
      Muhsin H. Younis, Xiaoli Lan and Weibo Cai
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 860-861; DOI: https://doi.org/10.2967/jnumed.121.263292

  2. Calais, Jeremie

    1. How Many Theranostics Centers Will We Need in the United States?
      Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 805-806; DOI: https://doi.org/10.2967/jnumed.122.264144
    2. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  3. Chantadisai, Maythinee

    1. Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671

  4. Chen, Chih-Shan Jason

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  5. Chen, Haojun

    1. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of <sup>68</sup>Ga-Labeled FAPI Dimer
      Open Access
      Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
      Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, Siyang Li, Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin and Haojun Chen
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 862-868; DOI: https://doi.org/10.2967/jnumed.121.263016

  6. Chen, Junyi

    1. Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
      Open Access
      Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
      Mengxin Xu, Pu Zhang, Jie Ding, Junyi Chen, Li Huo and Zhibo Liu
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 952-958; DOI: https://doi.org/10.2967/jnumed.121.262533

  7. Chen, Shuguang

    1. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low <sup>18</sup>F-FDG Activity
      Open Access
      Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low 18F-FDG Activity
      Yan Hu, Guobing Liu, Haojun Yu, Ying Wang, Chenwei Li, Hui Tan, Shuguang Chen, Jianying Gu and Hongcheng Shi
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 959-965; DOI: https://doi.org/10.2967/jnumed.121.262038

  8. Cordero, Jose

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  9. Cousins, Matthew M.

    1. Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore. S. Lawrence, Kyle C. Cuneo and Yuni K. Dewaraja
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 882-889; DOI: https://doi.org/10.2967/jnumed.121.262447

  10. Cuneo, Kyle C.

    1. Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore. S. Lawrence, Kyle C. Cuneo and Yuni K. Dewaraja
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 882-889; DOI: https://doi.org/10.2967/jnumed.121.262447

  11. Czernin, Johannes

    1. How Many Theranostics Centers Will We Need in the United States?
      Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 805-806; DOI: https://doi.org/10.2967/jnumed.122.264144
    2. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

D

  1. d’Alessandria, Calogero

    1. Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671

  2. D’Angelo, Sandra P.

    1. <sup>18</sup>F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
      18F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
      Sonia Mahajan, Christopher A. Barker, Audrey Mauguen, Sandra P. D’Angelo, Randy Yeh and Neeta Pandit-Taskar
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 906-911; DOI: https://doi.org/10.2967/jnumed.121.262882

  3. de Langen, Adrianus Johannes

    1. Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer <sup>18</sup>F-FDG PET Radiomics
      Open Access
      Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics
      Guilherme D. Kolinger, David Vállez García, Gerbrand Maria Kramer, Virginie Frings, Gerben J.C. Zwezerijnen, Egbert F. Smit, Adrianus Johannes de Langen, Irène Buvat and Ronald Boellaard
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 919-924; DOI: https://doi.org/10.2967/jnumed.121.262660

  4. Devasia, Theresa P.

    1. Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore. S. Lawrence, Kyle C. Cuneo and Yuni K. Dewaraja
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 882-889; DOI: https://doi.org/10.2967/jnumed.121.262447

  5. de Vries, Erik F.J.

    1. <sup>18</sup>F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Open Access
      18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Pieter H. Nienhuis, Inês F. Antunes, Andor W.J.M. Glaudemans, Mathilde Jalving, David Leung, Walter Noordzij, Riemer H.J.A. Slart, Erik F.J. de Vries and Geke A.P. Hospers
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 899-905; DOI: https://doi.org/10.2967/jnumed.121.262368

  6. Dewaraja, Yuni K.

    1. Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore. S. Lawrence, Kyle C. Cuneo and Yuni K. Dewaraja
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 882-889; DOI: https://doi.org/10.2967/jnumed.121.262447

  7. Dickson, Dennis W.

    1. Relationship Between <sup>18</sup>F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Relationship Between 18F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Keith A. Josephs, Nirubol Tosakulwong, Stephen D. Weigand, Marina Buciuc, Val J. Lowe, Dennis W. Dickson and Jennifer L. Whitwell
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 931-935; DOI: https://doi.org/10.2967/jnumed.121.262685

  8. Ding, Jie

    1. Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
      Open Access
      Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
      Mengxin Xu, Pu Zhang, Jie Ding, Junyi Chen, Li Huo and Zhibo Liu
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 952-958; DOI: https://doi.org/10.2967/jnumed.121.262533

  9. Dominguez, Celia

    1. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Open Access
      Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, Ignacio Munoz-Sanjuan and Steven Staelens
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 942-947; DOI: https://doi.org/10.2967/jnumed.121.262709

  10. Dusza, Stephen

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

E

  1. Eiber, Matthias

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398
    2. Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671

  2. Elashoff, David

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  3. Emmett, Louise M.

    1. The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
      Sze Ting Lee, Louise M. Emmett, David A. Pattison, Michael S. Hofman, Dale L. Bailey, Melissa J. Latter, Roslyn J. Francis and Andrew M. Scott
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 819-822; DOI: https://doi.org/10.2967/jnumed.122.263996

  4. Everett, Niasia

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

F

  1. Fang, Jianyang

    1. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of <sup>68</sup>Ga-Labeled FAPI Dimer
      Open Access
      Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
      Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, Siyang Li, Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin and Haojun Chen
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 862-868; DOI: https://doi.org/10.2967/jnumed.121.263016

  2. Felker, Ely R.

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  3. Fendler, Wolfgang P.

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808
    2. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  4. Ferdinandus, Justin

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808

  5. Feuerecker, Benedikt

    1. Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671

  6. Fox, Christi

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  7. Franca, Paula Demetrio Desouza

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  8. Francis, Roslyn J.

    1. The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
      Sze Ting Lee, Louise M. Emmett, David A. Pattison, Michael S. Hofman, Dale L. Bailey, Melissa J. Latter, Roslyn J. Francis and Andrew M. Scott
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 819-822; DOI: https://doi.org/10.2967/jnumed.122.263996

  9. Friedman, Nicholas C.

    1. The Will Rogers Phenomenon and PSMA PET/CT
      Nicholas C. Friedman and Edward Hines
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 966; DOI: https://doi.org/10.2967/jnumed.121.263556

  10. Frings, Virginie

    1. Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer <sup>18</sup>F-FDG PET Radiomics
      Open Access
      Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics
      Guilherme D. Kolinger, David Vállez García, Gerbrand Maria Kramer, Virginie Frings, Gerben J.C. Zwezerijnen, Egbert F. Smit, Adrianus Johannes de Langen, Irène Buvat and Ronald Boellaard
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 919-924; DOI: https://doi.org/10.2967/jnumed.121.262660

G

  1. García, David Vállez

    1. Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer <sup>18</sup>F-FDG PET Radiomics
      Open Access
      Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics
      Guilherme D. Kolinger, David Vállez García, Gerbrand Maria Kramer, Virginie Frings, Gerben J.C. Zwezerijnen, Egbert F. Smit, Adrianus Johannes de Langen, Irène Buvat and Ronald Boellaard
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 919-924; DOI: https://doi.org/10.2967/jnumed.121.262660

  2. Giovanella, Luca

    1. SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
      Anca M Avram, Luca Giovanella, Bennett Greenspan, Susan A. Lawson, Markus Luster, Douglas Van Nostrand, Justin G. Peacock, Petra Petranović Ovčariček, Edward Silberstein, Mark Tulchinsky, Frederik A. Verburg and Alexis Vrachimis
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 15N-35N;

  3. Glaudemans, Andor W.J.M.

    1. <sup>18</sup>F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Open Access
      18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Pieter H. Nienhuis, Inês F. Antunes, Andor W.J.M. Glaudemans, Mathilde Jalving, David Leung, Walter Noordzij, Riemer H.J.A. Slart, Erik F.J. de Vries and Geke A.P. Hospers
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 899-905; DOI: https://doi.org/10.2967/jnumed.121.262368

  4. Godbersen, Godber M.

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  5. Greenspan, Bennett

    1. SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
      Anca M Avram, Luca Giovanella, Bennett Greenspan, Susan A. Lawson, Markus Luster, Douglas Van Nostrand, Justin G. Peacock, Petra Petranović Ovčariček, Edward Silberstein, Mark Tulchinsky, Frederik A. Verburg and Alexis Vrachimis
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 15N-35N;

  6. Groaning, Michael

    1. Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
      Phillip H. Kuo, Taylor Benson, Richard Messmann and Michael Groaning
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 816-818; DOI: https://doi.org/10.2967/jnumed.121.263638

  7. Grogan, Tristan

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  8. Gryglewski, Gregor

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  9. Gu, Bingxin

    1. The Added Value of <sup>68</sup>Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with <sup>18</sup>F-FDG–Negative Findings
      Open Access
      The Added Value of 68Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with 18F-FDG–Negative Findings
      Bingxin Gu, Xiaoping Xu, Ji Zhang, Xiaomin Ou, Zuguang Xia, Qing Guan, Silong Hu, Zhongyi Yang and Shaoli Song
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 875-881; DOI: https://doi.org/10.2967/jnumed.121.262790

  10. Gu, Jianying

    1. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low <sup>18</sup>F-FDG Activity
      Open Access
      Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low 18F-FDG Activity
      Yan Hu, Guobing Liu, Haojun Yu, Ying Wang, Chenwei Li, Hui Tan, Shuguang Chen, Jianying Gu and Hongcheng Shi
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 959-965; DOI: https://doi.org/10.2967/jnumed.121.262038

  11. Guan, Qing

    1. The Added Value of <sup>68</sup>Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with <sup>18</sup>F-FDG–Negative Findings
      Open Access
      The Added Value of 68Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with 18F-FDG–Negative Findings
      Bingxin Gu, Xiaoping Xu, Ji Zhang, Xiaomin Ou, Zuguang Xia, Qing Guan, Silong Hu, Zhongyi Yang and Shaoli Song
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 875-881; DOI: https://doi.org/10.2967/jnumed.121.262790

  12. Guo, Zhide

    1. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of <sup>68</sup>Ga-Labeled FAPI Dimer
      Open Access
      Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
      Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, Siyang Li, Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin and Haojun Chen
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 862-868; DOI: https://doi.org/10.2967/jnumed.121.263016

H

  1. Hacker, Marcus

    1. Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Meiqi Wu, Jing Ning, Jingle Li, Zhichao Lai, Ximin Shi, Haiqun Xing, Marcus Hacker, Bao Liu, Li Huo and Xiang Li
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 948-951; DOI: https://doi.org/10.2967/jnumed.121.262863
    2. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  2. Hahn, Andreas

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  3. Haider, Ahmed

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  4. Halpern, Allan

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  5. Hamacher, Rainer

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808

  6. Handschuh, Patricia

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  7. Harris, Ucalene

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  8. Herrmann, Ken

    1. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797
    2. Prostate Cancer Treatment: 177Lu-PSMA-617 Considerations, Concepts, and Limitations
      Oliver Sartor and Ken Herrmann
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 823-829; DOI: https://doi.org/10.2967/jnumed.121.262413
    3. A Letter from Ukraine
      Ken Herrmann and Kmetyuk Yaroslav
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 807; DOI: https://doi.org/10.2967/jnumed.122.264288

  9. Hines, Edward

    1. The Will Rogers Phenomenon and PSMA PET/CT
      Nicholas C. Friedman and Edward Hines
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 966; DOI: https://doi.org/10.2967/jnumed.121.263556

  10. Hirmas, Nader

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808

  11. Hofman, Michael S.

    1. The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
      Sze Ting Lee, Louise M. Emmett, David A. Pattison, Michael S. Hofman, Dale L. Bailey, Melissa J. Latter, Roslyn J. Francis and Andrew M. Scott
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 819-822; DOI: https://doi.org/10.2967/jnumed.122.263996

  12. Hospers, Geke A.P.

    1. <sup>18</sup>F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Open Access
      18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Pieter H. Nienhuis, Inês F. Antunes, Andor W.J.M. Glaudemans, Mathilde Jalving, David Leung, Walter Noordzij, Riemer H.J.A. Slart, Erik F.J. de Vries and Geke A.P. Hospers
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 899-905; DOI: https://doi.org/10.2967/jnumed.121.262368

  13. House, Patrick M.

    1. Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck and Ralph Buchert
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 925-930; DOI: https://doi.org/10.2967/jnumed.121.262702

  14. Hu, Silong

    1. The Added Value of <sup>68</sup>Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with <sup>18</sup>F-FDG–Negative Findings
      Open Access
      The Added Value of 68Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with 18F-FDG–Negative Findings
      Bingxin Gu, Xiaoping Xu, Ji Zhang, Xiaomin Ou, Zuguang Xia, Qing Guan, Silong Hu, Zhongyi Yang and Shaoli Song
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 875-881; DOI: https://doi.org/10.2967/jnumed.121.262790

  15. Hu, Yan

    1. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low <sup>18</sup>F-FDG Activity
      Open Access
      Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low 18F-FDG Activity
      Yan Hu, Guobing Liu, Haojun Yu, Ying Wang, Chenwei Li, Hui Tan, Shuguang Chen, Jianying Gu and Hongcheng Shi
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 959-965; DOI: https://doi.org/10.2967/jnumed.121.262038

  16. Huo, Li

    1. Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Meiqi Wu, Jing Ning, Jingle Li, Zhichao Lai, Ximin Shi, Haiqun Xing, Marcus Hacker, Bao Liu, Li Huo and Xiang Li
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 948-951; DOI: https://doi.org/10.2967/jnumed.121.262863
    2. Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
      Open Access
      Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
      Mengxin Xu, Pu Zhang, Jie Ding, Junyi Chen, Li Huo and Zhibo Liu
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 952-958; DOI: https://doi.org/10.2967/jnumed.121.262533

I

  1. Iagaru, Andrei

    1. 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
      Hong Song, Andrei Iagaru and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 855-859; DOI: https://doi.org/10.2967/jnumed.121.262989

J

  1. Jaber, Mariam

    1. Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck and Ralph Buchert
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 925-930; DOI: https://doi.org/10.2967/jnumed.121.262702

  2. Jadvar, Hossein

    1. Nuclear Medicine Textbook: Methodology and Clinical Applications
      Hossein Jadvar
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 967; DOI: https://doi.org/10.2967/jnumed.121.263612
    2. The VISION Forward: Recognition and Implication of PSMA−/18F-FDG+ mCRPC
      Hossein Jadvar
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 812-815; DOI: https://doi.org/10.2967/jnumed.121.263274

  3. Jain, Manu

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  4. Jalving, Mathilde

    1. <sup>18</sup>F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Open Access
      18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Pieter H. Nienhuis, Inês F. Antunes, Andor W.J.M. Glaudemans, Mathilde Jalving, David Leung, Walter Noordzij, Riemer H.J.A. Slart, Erik F.J. de Vries and Geke A.P. Hospers
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 899-905; DOI: https://doi.org/10.2967/jnumed.121.262368

  5. Jentzen, Walter

    1. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  6. Joie, Renaud La

    1. Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials
      Maura Malpetti, Renaud La Joie and Gil D. Rabinovici
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 830-832; DOI: https://doi.org/10.2967/jnumed.121.263694

  7. Josephs, Keith A.

    1. Relationship Between <sup>18</sup>F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Relationship Between 18F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Keith A. Josephs, Nirubol Tosakulwong, Stephen D. Weigand, Marina Buciuc, Val J. Lowe, Dennis W. Dickson and Jennifer L. Whitwell
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 931-935; DOI: https://doi.org/10.2967/jnumed.121.262685

K

  1. Kaza, Ravi K.

    1. Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore. S. Lawrence, Kyle C. Cuneo and Yuni K. Dewaraja
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 882-889; DOI: https://doi.org/10.2967/jnumed.121.262447

  2. Kazek, Sandra

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808

  3. Kersting, David

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808

  4. Kessler, Lukas

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808

  5. Kim, Yong-il

    1. Effects of <sup>225</sup>Ac-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis
      Effects of 225Ac-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis
      Dong Yun Lee and Yong-il Kim
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 840-846; DOI: https://doi.org/10.2967/jnumed.121.262017

  6. Klutmann, Susanne

    1. Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck and Ralph Buchert
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 925-930; DOI: https://doi.org/10.2967/jnumed.121.262702

  7. Kolinger, Guilherme D.

    1. Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer <sup>18</sup>F-FDG PET Radiomics
      Open Access
      Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics
      Guilherme D. Kolinger, David Vállez García, Gerbrand Maria Kramer, Virginie Frings, Gerben J.C. Zwezerijnen, Egbert F. Smit, Adrianus Johannes de Langen, Irène Buvat and Ronald Boellaard
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 919-924; DOI: https://doi.org/10.2967/jnumed.121.262660

  8. Kose, Kivanc

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  9. Kossatz, Susanne

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  10. Kostakoglu, Lale

    1. Precision Medicine Clinical Trials
      Peter J. O’Dwyer and Lale Kostakoglu
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 808-811; DOI: https://doi.org/10.2967/jnumed.121.264320

  11. Kramer, Gerbrand Maria

    1. Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer <sup>18</sup>F-FDG PET Radiomics
      Open Access
      Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics
      Guilherme D. Kolinger, David Vállez García, Gerbrand Maria Kramer, Virginie Frings, Gerben J.C. Zwezerijnen, Egbert F. Smit, Adrianus Johannes de Langen, Irène Buvat and Ronald Boellaard
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 919-924; DOI: https://doi.org/10.2967/jnumed.121.262660

  12. Kumar, Piyush

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  13. Kuo, Phillip H.

    1. Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
      Phillip H. Kuo, Taylor Benson, Richard Messmann and Michael Groaning
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 816-818; DOI: https://doi.org/10.2967/jnumed.121.263638

  14. Kurtansky, Nicholas R.

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

L

  1. Lai, Zhichao

    1. Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Meiqi Wu, Jing Ning, Jingle Li, Zhichao Lai, Ximin Shi, Haiqun Xing, Marcus Hacker, Bao Liu, Li Huo and Xiang Li
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 948-951; DOI: https://doi.org/10.2967/jnumed.121.262863

  2. Lan, Xiaoli

    1. PET with a 68Ga-Labeled FAPI Dimer: Moving Toward Theranostics
      Muhsin H. Younis, Xiaoli Lan and Weibo Cai
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 860-861; DOI: https://doi.org/10.2967/jnumed.121.263292

  3. Lanz, Michael

    1. Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck and Ralph Buchert
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 925-930; DOI: https://doi.org/10.2967/jnumed.121.262702

  4. Lanzenberger, Rupert

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  5. Latter, Melissa J.

    1. The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
      Sze Ting Lee, Louise M. Emmett, David A. Pattison, Michael S. Hofman, Dale L. Bailey, Melissa J. Latter, Roslyn J. Francis and Andrew M. Scott
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 819-822; DOI: https://doi.org/10.2967/jnumed.122.263996

  6. Lawrence, Theodore. S.

    1. Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore. S. Lawrence, Kyle C. Cuneo and Yuni K. Dewaraja
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 882-889; DOI: https://doi.org/10.2967/jnumed.121.262447

  7. Lawson, Susan A.

    1. SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
      Anca M Avram, Luca Giovanella, Bennett Greenspan, Susan A. Lawson, Markus Luster, Douglas Van Nostrand, Justin G. Peacock, Petra Petranović Ovčariček, Edward Silberstein, Mark Tulchinsky, Frederik A. Verburg and Alexis Vrachimis
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 15N-35N;

  8. Lee, Dong Yun

    1. Effects of <sup>225</sup>Ac-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis
      Effects of 225Ac-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis
      Dong Yun Lee and Yong-il Kim
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 840-846; DOI: https://doi.org/10.2967/jnumed.121.262017

  9. Lee, Erica

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  10. Lee, Sze Ting

    1. The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
      Sze Ting Lee, Louise M. Emmett, David A. Pattison, Michael S. Hofman, Dale L. Bailey, Melissa J. Latter, Roslyn J. Francis and Andrew M. Scott
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 819-822; DOI: https://doi.org/10.2967/jnumed.122.263996

  11. Lenis, Andrew T.

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  12. Leung, David

    1. <sup>18</sup>F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Open Access
      18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Pieter H. Nienhuis, Inês F. Antunes, Andor W.J.M. Glaudemans, Mathilde Jalving, David Leung, Walter Noordzij, Riemer H.J.A. Slart, Erik F.J. de Vries and Geke A.P. Hospers
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 899-905; DOI: https://doi.org/10.2967/jnumed.121.262368

  13. Li, Chenwei

    1. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low <sup>18</sup>F-FDG Activity
      Open Access
      Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low 18F-FDG Activity
      Yan Hu, Guobing Liu, Haojun Yu, Ying Wang, Chenwei Li, Hui Tan, Shuguang Chen, Jianying Gu and Hongcheng Shi
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 959-965; DOI: https://doi.org/10.2967/jnumed.121.262038

  14. Li, Jingle

    1. Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Meiqi Wu, Jing Ning, Jingle Li, Zhichao Lai, Ximin Shi, Haiqun Xing, Marcus Hacker, Bao Liu, Li Huo and Xiang Li
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 948-951; DOI: https://doi.org/10.2967/jnumed.121.262863

  15. Li, Siyang

    1. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of <sup>68</sup>Ga-Labeled FAPI Dimer
      Open Access
      Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
      Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, Siyang Li, Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin and Haojun Chen
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 862-868; DOI: https://doi.org/10.2967/jnumed.121.263016

  16. Li, Xiang

    1. Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Meiqi Wu, Jing Ning, Jingle Li, Zhichao Lai, Ximin Shi, Haiqun Xing, Marcus Hacker, Bao Liu, Li Huo and Xiang Li
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 948-951; DOI: https://doi.org/10.2967/jnumed.121.262863

  17. Lin, Qin

    1. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of <sup>68</sup>Ga-Labeled FAPI Dimer
      Open Access
      Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
      Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, Siyang Li, Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin and Haojun Chen
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 862-868; DOI: https://doi.org/10.2967/jnumed.121.263016

  18. Lindenau, Matthias

    1. Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck and Ralph Buchert
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 925-930; DOI: https://doi.org/10.2967/jnumed.121.262702

  19. Liu, Bao

    1. Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Meiqi Wu, Jing Ning, Jingle Li, Zhichao Lai, Ximin Shi, Haiqun Xing, Marcus Hacker, Bao Liu, Li Huo and Xiang Li
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 948-951; DOI: https://doi.org/10.2967/jnumed.121.262863

  20. Liu, Guobing

    1. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low <sup>18</sup>F-FDG Activity
      Open Access
      Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low 18F-FDG Activity
      Yan Hu, Guobing Liu, Haojun Yu, Ying Wang, Chenwei Li, Hui Tan, Shuguang Chen, Jianying Gu and Hongcheng Shi
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 959-965; DOI: https://doi.org/10.2967/jnumed.121.262038

  21. Liu, Longbin

    1. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Open Access
      Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, Ignacio Munoz-Sanjuan and Steven Staelens
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 942-947; DOI: https://doi.org/10.2967/jnumed.121.262709

  22. Liu, Zhibo

    1. Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
      Open Access
      Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
      Mengxin Xu, Pu Zhang, Jie Ding, Junyi Chen, Li Huo and Zhibo Liu
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 952-958; DOI: https://doi.org/10.2967/jnumed.121.262533

  23. Longo, Caterina

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  24. Lowe, Val J.

    1. Relationship Between <sup>18</sup>F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Relationship Between 18F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Keith A. Josephs, Nirubol Tosakulwong, Stephen D. Weigand, Marina Buciuc, Val J. Lowe, Dennis W. Dickson and Jennifer L. Whitwell
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 931-935; DOI: https://doi.org/10.2967/jnumed.121.262685

  25. Lueckerath, Katharina

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808

  26. Luster, Markus

    1. SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
      Anca M Avram, Luca Giovanella, Bennett Greenspan, Susan A. Lawson, Markus Luster, Douglas Van Nostrand, Justin G. Peacock, Petra Petranović Ovčariček, Edward Silberstein, Mark Tulchinsky, Frederik A. Verburg and Alexis Vrachimis
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 15N-35N;

M

  1. Mahajan, Sonia

    1. <sup>18</sup>F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
      18F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
      Sonia Mahajan, Christopher A. Barker, Audrey Mauguen, Sandra P. D’Angelo, Randy Yeh and Neeta Pandit-Taskar
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 906-911; DOI: https://doi.org/10.2967/jnumed.121.262882

  2. Malpetti, Maura

    1. Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials
      Maura Malpetti, Renaud La Joie and Gil D. Rabinovici
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 830-832; DOI: https://doi.org/10.2967/jnumed.121.263694

  3. Maric, Ines

    1. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  4. Martens, Tobias

    1. Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck and Ralph Buchert
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 925-930; DOI: https://doi.org/10.2967/jnumed.121.262702

  5. Mauguen, Audrey

    1. <sup>18</sup>F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
      18F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
      Sonia Mahajan, Christopher A. Barker, Audrey Mauguen, Sandra P. D’Angelo, Randy Yeh and Neeta Pandit-Taskar
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 906-911; DOI: https://doi.org/10.2967/jnumed.121.262882

  6. Maurino, Christopher M.

    1. Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore. S. Lawrence, Kyle C. Cuneo and Yuni K. Dewaraja
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 882-889; DOI: https://doi.org/10.2967/jnumed.121.262447

  7. Messmann, Richard

    1. Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
      Phillip H. Kuo, Taylor Benson, Richard Messmann and Michael Groaning
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 816-818; DOI: https://doi.org/10.2967/jnumed.121.263638

  8. Mikell, Justin

    1. Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore. S. Lawrence, Kyle C. Cuneo and Yuni K. Dewaraja
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 882-889; DOI: https://doi.org/10.2967/jnumed.121.262447

  9. Mindt, Thomas

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  10. Miranda, Alan

    1. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Open Access
      Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, Ignacio Munoz-Sanjuan and Steven Staelens
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 942-947; DOI: https://doi.org/10.2967/jnumed.121.262709

  11. Mitterhauser, Markus

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  12. Monnier, Jilliana

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  13. Mrzljak, Ladislav

    1. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Open Access
      Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, Ignacio Munoz-Sanjuan and Steven Staelens
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 942-947; DOI: https://doi.org/10.2967/jnumed.121.262709

  14. Munoz-Sanjuan, Ignacio

    1. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Open Access
      Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, Ignacio Munoz-Sanjuan and Steven Staelens
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 942-947; DOI: https://doi.org/10.2967/jnumed.121.262709

  15. Murgaš, Matej

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

N

  1. Nader, Michael

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808

  2. Nehal, Kishwer

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  3. Nics, Lukas

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  4. Nienhuis, Pieter H.

    1. <sup>18</sup>F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Open Access
      18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Pieter H. Nienhuis, Inês F. Antunes, Andor W.J.M. Glaudemans, Mathilde Jalving, David Leung, Walter Noordzij, Riemer H.J.A. Slart, Erik F.J. de Vries and Geke A.P. Hospers
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 899-905; DOI: https://doi.org/10.2967/jnumed.121.262368

  5. Nimmagadda, Sridhar

    1. Imaging PD-L1 Expression in Melanoma Brain Metastases
      Sridhar Nimmagadda
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 897-898; DOI: https://doi.org/10.2967/jnumed.121.263209

  6. Ning, Jing

    1. Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Meiqi Wu, Jing Ning, Jingle Li, Zhichao Lai, Ximin Shi, Haiqun Xing, Marcus Hacker, Bao Liu, Li Huo and Xiang Li
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 948-951; DOI: https://doi.org/10.2967/jnumed.121.262863

  7. Niu, Bo

    1. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of <sup>68</sup>Ga-Labeled FAPI Dimer
      Open Access
      Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
      Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, Siyang Li, Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin and Haojun Chen
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 862-868; DOI: https://doi.org/10.2967/jnumed.121.263016

  8. Noordzij, Walter

    1. <sup>18</sup>F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Open Access
      18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Pieter H. Nienhuis, Inês F. Antunes, Andor W.J.M. Glaudemans, Mathilde Jalving, David Leung, Walter Noordzij, Riemer H.J.A. Slart, Erik F.J. de Vries and Geke A.P. Hospers
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 899-905; DOI: https://doi.org/10.2967/jnumed.121.262368

O

  1. O’Dwyer, Peter J.

    1. Precision Medicine Clinical Trials
      Peter J. O’Dwyer and Lale Kostakoglu
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 808-811; DOI: https://doi.org/10.2967/jnumed.121.264320

  2. Ou, Xiaomin

    1. The Added Value of <sup>68</sup>Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with <sup>18</sup>F-FDG–Negative Findings
      Open Access
      The Added Value of 68Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with 18F-FDG–Negative Findings
      Bingxin Gu, Xiaoping Xu, Ji Zhang, Xiaomin Ou, Zuguang Xia, Qing Guan, Silong Hu, Zhongyi Yang and Shaoli Song
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 875-881; DOI: https://doi.org/10.2967/jnumed.121.262790

  3. Ovčariček, Petra Petranović

    1. SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
      Anca M Avram, Luca Giovanella, Bennett Greenspan, Susan A. Lawson, Markus Luster, Douglas Van Nostrand, Justin G. Peacock, Petra Petranović Ovčariček, Edward Silberstein, Mark Tulchinsky, Frederik A. Verburg and Alexis Vrachimis
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 15N-35N;

P

  1. Pabst, Kim

    1. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  2. Pandit-Taskar, Neeta

    1. <sup>18</sup>F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
      18F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma
      Sonia Mahajan, Christopher A. Barker, Audrey Mauguen, Sandra P. D’Angelo, Randy Yeh and Neeta Pandit-Taskar
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 906-911; DOI: https://doi.org/10.2967/jnumed.121.262882

  3. Pang, Yizhen

    1. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of <sup>68</sup>Ga-Labeled FAPI Dimer
      Open Access
      Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
      Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, Siyang Li, Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin and Haojun Chen
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 862-868; DOI: https://doi.org/10.2967/jnumed.121.263016

  4. Pattison, David A.

    1. The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
      Sze Ting Lee, Louise M. Emmett, David A. Pattison, Michael S. Hofman, Dale L. Bailey, Melissa J. Latter, Roslyn J. Francis and Andrew M. Scott
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 819-822; DOI: https://doi.org/10.2967/jnumed.122.263996

  5. Peacock, Justin G.

    1. SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
      Anca M Avram, Luca Giovanella, Bennett Greenspan, Susan A. Lawson, Markus Luster, Douglas Van Nostrand, Justin G. Peacock, Petra Petranović Ovčariček, Edward Silberstein, Mark Tulchinsky, Frederik A. Verburg and Alexis Vrachimis
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 15N-35N;

  6. Phillips, William

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  7. Pichler, Verena

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  8. Poeppel, Thorsten D.

    1. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  9. Pulitzer, Melissa

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

R

  1. Rabinovici, Gil D.

    1. Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials
      Maura Malpetti, Renaud La Joie and Gil D. Rabinovici
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 830-832; DOI: https://doi.org/10.2967/jnumed.121.263694

  2. Rajadhyaksha, Milind

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  3. Raman, Steven S.

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  4. Rasul, Sazan

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  5. Rauscher, Isabel

    1. Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671

  6. Reiner, Thomas

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  7. Reiter, Robert E.

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  8. Rischka, Lucas

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  9. Rischpler, Christoph

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808
    2. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  10. Roberts, Sheryl

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  11. Rossi, Anthony

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  12. Rowe, Steven P.

    1. 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
      Hong Song, Andrei Iagaru and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 855-859; DOI: https://doi.org/10.2967/jnumed.121.262989

S

  1. Sahu, Aditi

    1. Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma
      Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600

  2. Sartor, Oliver

    1. Prostate Cancer Treatment: 177Lu-PSMA-617 Considerations, Concepts, and Limitations
      Oliver Sartor and Ken Herrmann
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 823-829; DOI: https://doi.org/10.2967/jnumed.121.262413

  3. Sauvigny, Thomas

    1. Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck and Ralph Buchert
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 925-930; DOI: https://doi.org/10.2967/jnumed.121.262702

  4. Schibli, Roger

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  5. Schipper, Matthew J.

    1. Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
      Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore. S. Lawrence, Kyle C. Cuneo and Yuni K. Dewaraja
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 882-889; DOI: https://doi.org/10.2967/jnumed.121.262447

  6. Schmitz, Jochen

    1. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  7. Scott, Andrew M.

    1. The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective
      Sze Ting Lee, Louise M. Emmett, David A. Pattison, Michael S. Hofman, Dale L. Bailey, Melissa J. Latter, Roslyn J. Francis and Andrew M. Scott
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 819-822; DOI: https://doi.org/10.2967/jnumed.122.263996

  8. Shi, Hongcheng

    1. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low <sup>18</sup>F-FDG Activity
      Open Access
      Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low 18F-FDG Activity
      Yan Hu, Guobing Liu, Haojun Yu, Ying Wang, Chenwei Li, Hui Tan, Shuguang Chen, Jianying Gu and Hongcheng Shi
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 959-965; DOI: https://doi.org/10.2967/jnumed.121.262038

  9. Shi, Ximin

    1. Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls
      Meiqi Wu, Jing Ning, Jingle Li, Zhichao Lai, Ximin Shi, Haiqun Xing, Marcus Hacker, Bao Liu, Li Huo and Xiang Li
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 948-951; DOI: https://doi.org/10.2967/jnumed.121.262863

  10. Silberbauer, Leo R.

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  11. Silberstein, Edward

    1. SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
      Anca M Avram, Luca Giovanella, Bennett Greenspan, Susan A. Lawson, Markus Luster, Douglas Van Nostrand, Justin G. Peacock, Petra Petranović Ovčariček, Edward Silberstein, Mark Tulchinsky, Frederik A. Verburg and Alexis Vrachimis
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 15N-35N;

  12. Sisk, Anthony E.

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  13. Skinbjerg, Mette

    1. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Open Access
      Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, Ignacio Munoz-Sanjuan and Steven Staelens
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 942-947; DOI: https://doi.org/10.2967/jnumed.121.262709

  14. Slart, Riemer H.J.A.

    1. <sup>18</sup>F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Open Access
      18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
      Pieter H. Nienhuis, Inês F. Antunes, Andor W.J.M. Glaudemans, Mathilde Jalving, David Leung, Walter Noordzij, Riemer H.J.A. Slart, Erik F.J. de Vries and Geke A.P. Hospers
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 899-905; DOI: https://doi.org/10.2967/jnumed.121.262368

  15. Smit, Egbert F.

    1. Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer <sup>18</sup>F-FDG PET Radiomics
      Open Access
      Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics
      Guilherme D. Kolinger, David Vállez García, Gerbrand Maria Kramer, Virginie Frings, Gerben J.C. Zwezerijnen, Egbert F. Smit, Adrianus Johannes de Langen, Irène Buvat and Ronald Boellaard
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 919-924; DOI: https://doi.org/10.2967/jnumed.121.262660

  16. Song, Hong

    1. 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
      Hong Song, Andrei Iagaru and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 855-859; DOI: https://doi.org/10.2967/jnumed.121.262989

  17. Song, Shaoli

    1. The Added Value of <sup>68</sup>Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with <sup>18</sup>F-FDG–Negative Findings
      Open Access
      The Added Value of 68Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with 18F-FDG–Negative Findings
      Bingxin Gu, Xiaoping Xu, Ji Zhang, Xiaomin Ou, Zuguang Xia, Qing Guan, Silong Hu, Zhongyi Yang and Shaoli Song
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 875-881; DOI: https://doi.org/10.2967/jnumed.121.262790

  18. Sonni, Ida

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  19. Sraieb, Miriam

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808

  20. Staelens, Steven

    1. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Open Access
      Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, Ignacio Munoz-Sanjuan and Steven Staelens
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 942-947; DOI: https://doi.org/10.2967/jnumed.121.262709

  21. Steinhelfer, Lisa

    1. Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671

  22. Stodieck, Stefan

    1. Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck and Ralph Buchert
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 925-930; DOI: https://doi.org/10.2967/jnumed.121.262702

  23. Stroobants, Sigrid

    1. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Open Access
      Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, Ignacio Munoz-Sanjuan and Steven Staelens
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 942-947; DOI: https://doi.org/10.2967/jnumed.121.262709

  24. Sun, Long

    1. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of <sup>68</sup>Ga-Labeled FAPI Dimer
      Open Access
      Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
      Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, Siyang Li, Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin and Haojun Chen
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 862-868; DOI: https://doi.org/10.2967/jnumed.121.263016

  25. Suvannarerg, Voraparee

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

T

  1. Taherpour, Jila

    1. Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck and Ralph Buchert
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 925-930; DOI: https://doi.org/10.2967/jnumed.121.262702

  2. Tan, Hui

    1. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low <sup>18</sup>F-FDG Activity
      Open Access
      Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low 18F-FDG Activity
      Yan Hu, Guobing Liu, Haojun Yu, Ying Wang, Chenwei Li, Hui Tan, Shuguang Chen, Jianying Gu and Hongcheng Shi
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 959-965; DOI: https://doi.org/10.2967/jnumed.121.262038

  3. Tauber, Robert

    1. Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671

  4. Theurer, Sarah

    1. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  5. Tosakulwong, Nirubol

    1. Relationship Between <sup>18</sup>F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Relationship Between 18F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Keith A. Josephs, Nirubol Tosakulwong, Stephen D. Weigand, Marina Buciuc, Val J. Lowe, Dennis W. Dickson and Jennifer L. Whitwell
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 931-935; DOI: https://doi.org/10.2967/jnumed.121.262685

  6. Tubtawee, Teeravut

    1. Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
      Ida Sonni, Ely R. Felker, Andrew T. Lenis, Anthony E. Sisk, Shadfar Bahri, Martin Allen-Auerbach, Wesley R. Armstrong, Voraparee Suvannarerg, Teeravut Tubtawee, Tristan Grogan, David Elashoff, Matthias Eiber, Steven S. Raman, Johannes Czernin, Robert E. Reiter and Jeremie Calais
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 847-854; DOI: https://doi.org/10.2967/jnumed.121.262398

  7. Tulchinsky, Mark

    1. SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
      Anca M Avram, Luca Giovanella, Bennett Greenspan, Susan A. Lawson, Markus Luster, Douglas Van Nostrand, Justin G. Peacock, Petra Petranović Ovčariček, Edward Silberstein, Mark Tulchinsky, Frederik A. Verburg and Alexis Vrachimis
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 15N-35N;

U

  1. Umutlu, Lale

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808
    2. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  2. Unger, Nicole

    1. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  3. Unterholzner, Jakob

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

V

  1. Van Nostrand, Douglas

    1. SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
      Anca M Avram, Luca Giovanella, Bennett Greenspan, Susan A. Lawson, Markus Luster, Douglas Van Nostrand, Justin G. Peacock, Petra Petranović Ovčariček, Edward Silberstein, Mark Tulchinsky, Frederik A. Verburg and Alexis Vrachimis
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 15N-35N;

  2. Verburg, Frederik A.

    1. SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
      Anca M Avram, Luca Giovanella, Bennett Greenspan, Susan A. Lawson, Markus Luster, Douglas Van Nostrand, Justin G. Peacock, Petra Petranović Ovčariček, Edward Silberstein, Mark Tulchinsky, Frederik A. Verburg and Alexis Vrachimis
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 15N-35N;

  3. Verhaeghe, Jeroen

    1. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Open Access
      Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
      Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, Ignacio Munoz-Sanjuan and Steven Staelens
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 942-947; DOI: https://doi.org/10.2967/jnumed.121.262709

  4. Voges, Berthold

    1. Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
      Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck and Ralph Buchert
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 925-930; DOI: https://doi.org/10.2967/jnumed.121.262702

  5. Vrachimis, Alexis

    1. SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
      Anca M Avram, Luca Giovanella, Bennett Greenspan, Susan A. Lawson, Markus Luster, Douglas Van Nostrand, Justin G. Peacock, Petra Petranović Ovčariček, Edward Silberstein, Mark Tulchinsky, Frederik A. Verburg and Alexis Vrachimis
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 15N-35N;

  6. Vraka, Chrysoula

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

W

  1. Wadsak, Wolfgang

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  2. Wahl, Richard L.

    1. SNMMI Leadership Update: Putting Patients First: A Year in Review
      Richard L. Wahl
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 14N;

  3. Walz, Martin

    1. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  4. Wang, Ying

    1. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low <sup>18</sup>F-FDG Activity
      Open Access
      Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low 18F-FDG Activity
      Yan Hu, Guobing Liu, Haojun Yu, Ying Wang, Chenwei Li, Hui Tan, Shuguang Chen, Jianying Gu and Hongcheng Shi
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 959-965; DOI: https://doi.org/10.2967/jnumed.121.262038

  5. Weber, Frank

    1. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  6. Weber, Manuel

    1. Pitfalls and Common Findings in <sup>68</sup>Ga-FAPI PET: A Pictorial Analysis
      Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
      Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808
    2. Diagnostic Performance of <sup>124</sup>I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
      Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797

  7. Weber, Wolfgang A.

    1. Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671

  8. Weigand, Stephen D.

    1. Relationship Between <sup>18</sup>F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Relationship Between 18F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Keith A. Josephs, Nirubol Tosakulwong, Stephen D. Weigand, Marina Buciuc, Val J. Lowe, Dennis W. Dickson and Jennifer L. Whitwell
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 931-935; DOI: https://doi.org/10.2967/jnumed.121.262685

  9. Wester, Hans-Jürgen

    1. Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
      Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671

  10. Whitwell, Jennifer L.

    1. Relationship Between <sup>18</sup>F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Relationship Between 18F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies
      Keith A. Josephs, Nirubol Tosakulwong, Stephen D. Weigand, Marina Buciuc, Val J. Lowe, Dennis W. Dickson and Jennifer L. Whitwell
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 931-935; DOI: https://doi.org/10.2967/jnumed.121.262685

  11. Wotawa, Christoph

    1. First-in-Humans Brain PET Imaging of the GluN2B-Containing <em>N</em>-methyl-<span class="sc">d</span>-aspartate Receptor with (<em>R</em>)-<sup>11</sup>C-Me-NB1
      First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1
      Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker and Simon M. Ametamey
      Journal of Nuclear Medicine June 1, 2022, 63 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.121.262427

  12. Wu, Meiqi